Traws Pharma earnings were -$16.7M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest TRAW earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.6M, down 54.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TRAW reported annual earnings of $6.9M, with -112.6% growth. The next TRAW earnings date is Nov 12, 2026.
On TRAW's earnings call on Aug 13, 2026, Traws Pharma (NASDAQ: TRAW) reported Q2 2026 earnings per share (EPS) of -$0.16, up 45.45% year over year. Total TRAW earnings for the quarter were -$2.61 million. In the same quarter last year, Traws Pharma's earnings per share (EPS) was -$0.11.
The next TRAW earnings call is Nov 12, 2026. Add TRAW to your watchlist to be reminded of Traws Pharma's next earnings date.
Is Traws Pharma profitable or losing money?
As of the last Traws Pharma earnings report, Traws Pharma is currently losing money. Traws Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$16.74 million, a 99.38% increase year over year.
What was TRAW's earnings growth in the past year?
As of Traws Pharma's earnings date in Aug 13, 2026, Traws Pharma's earnings has grown year over year. TRAW earnings in the past year totalled -$16.74 million.
What are Traws Pharma's earnings expectations?
The current EPS estimate for Traws Pharma's earnings report in Nov 12, 2026 is -$0.21.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.